City
Epaper

Gopal's 56 Opens Master Franchise Doors: A Rare Business Opportunity to Lead a Statewide F&B Revolution

By ANI | Updated: May 19, 2025 18:07 IST

VMPLNew Delhi [India], May 19: Gopal's 56, the iconic Indian brand known for its Ayurvedic, vegan, and zero-sugar ...

Open in App

VMPL

New Delhi [India], May 19: Gopal's 56, the iconic Indian brand known for its Ayurvedic, vegan, and zero-sugar frozen desserts, has announced a major expansion move by offering Master Franchise rights for one full Indian statea strategic step that marks a significant milestone in the brand's nationwide growth journey.

With a 40-year legacy of innovation and trust, Gopal's 56 is inviting seasoned entrepreneurs, hospitality investors, and food retail operators to partner and lead the brand's presence in new regions.

"This is not just a franchiseit's an invitation to become a change-maker in the food and wellness space," said Dr. Gaurav Goyal, MD & CEO of Gopal's 56. "We're offering exclusive rights, deep operational support, and a chance to scale with a globally recognized Indian brand."

A Brand with Global Recognition

From humble beginnings in Delhi to international success in California and Ontario, Gopal's 56 has carved a niche with:

Fiber-infused, zero-calorie ice creams

Probiotic shakes

Vegan Ayurvedic blends like Charanamrit, Tom & Jerry, and Love Potion

The brand was recently featured on Shark Tank India with a Rs300 crore pitchthe highest ask in the show's historyand has earned praise from the UK Parliament and UAE wellness forums for redefining indulgence.

Master Franchise Rights: What's on Offer?

The Master Franchise opportunity gives the partner:

Exclusive rights to develop the brand across an entire state

Control over outlet development, sub-franchising, and state-level branding

Full support in training, R&D, supply chain, marketing, and operations

Investment & Expectations

Required Investment: Rs1.5 to Rs2.5 Crores (based on state potential)

Ideal Partner Profile: Regional players in food retail, established entrepreneurs, or business houses with a focus on quality and scalability

The Call for Visionary Partners

"We are seeking a partner, not just an investor. Someone who shares our passion for food innovation, tradition, and wellness," adds Dr. Goyal.

With increasing consumer demand for functional and guilt-free indulgences, this opportunity comes at a time when the Indian F&B sector is poised for a health-centric transformation.

Contact Details for Franchise Interest

Email: gauravgoyal@gopals56.org

Phone: +91 82875 39577

Website: www.gopals56.in

A once-in-a-decade opportunity is here.

Gopal's 56 invites you to be the face of their state-wide revolution in flavor and wellness.

Because at Gopal's 56 tradition isn't just preserved, it's reinvented.

(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL.will not be responsible in any way for the content of the same)

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalCloudburst in Pakistan's Gilgit-Baltistan kills 5 tourists, rescue ops underway

EntertainmentJuhi Chawla shares son’s birthday with throwback pictures, plants 500 trees for his well being

InternationalFive children killed in Swat as monsoon floods ravage Pakistan's Khyber Pakhtunkhwa

InternationalUS House Republicans push to rename Kennedy Center Opera House after Melania Trump

International"Seminal point of the visit Is signing FTA": Ex-Diplomat on PM Modi's UK trip

Business Realted Stories

BusinessStand-Up India Scheme sanctions nearly Rs 29,000 crore to SC/ST, women entrepreneurs since April 2022

BusinessMain negotiations around India-UK FTA concluded, ready to welcome PM Modi: Vikram Doraiswami

BusinessUP Cabinet approves 1 pc stamp duty exemption for women on property worth up to Rs 1 crore

BusinessRajasthan's Indraj builds thriving nursery business with Rs 10 lakh Mudra loan

Business48 projects approved to avoid disruption in supply of critical active pharma ingredients